| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Cell &Genetic Therapies
2 companies
Sanna Bastiano is an EVP, Cell &Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 31 sells.
Estimated insider holdings value: $14.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 45 | $252.83 | $11,377.26 | - | +20.2% | +35.8% | |
| May 4, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 36 | $275.09 | $9,903.24 | - | +0.1% | +26.6% | |
| May 2, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 320 | $259.16 | $82,929.73 | -0.1% | +4.5% | +32.1% | |
| Apr 7, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 561 | $276.18 | $154,934.97 | -0.4% | +5.6% | +16.6% | |
| Apr 5, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 3,725 | $274.10 | $1,021,004.50 | -2.7% | +7.0% | +19.3% | |
| Mar 17, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 2,122 | $250.06 | $530,627.32 | -4.2% | +1.4% | +18.3% | |
| Feb 2, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 1,040 | $250.98 | $261,016.94 | -0.4% | +6.1% | +19.8% | |
| May 17, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 112 | $216.34 | $24,230.11 | -0.2% | -11.7% | +21.0% | |
| May 3, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 960 | $218.43 | $209,691.03 | -1.4% | -9.0% | +23.5% | |
| Apr 5, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 1,686 | $214.14 | $361,046.44 | -2.3% | -7.1% | +25.4% |